SCHEMBL13066443

SCHEMBL13066443

CN/C(N)=N\C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8226636 1.00
SCHEMBL1682918 1.00
SCHEMBL8966434 0.78 POLB (0.30)
SCHEMBL12491703 0.74
SCHEMBL11692067 0.74
SCHEMBL21597153 0.74
SCHEMBL7619934 0.72
SCHEMBL27453694 0.72
SCHEMBL7619936 0.72
SCHEMBL9186924 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10933049-B2 Mobilizing agents and uses therefor THE UNIVERSITY OF QUEENSLAND (AU) 2021-03-02 US disclosed
EP-2776411-B1 MODULATORS OF C3A RECEPTORS UNIV QUEENSLAND (AU) 2019-06-26 EP disclosed
US-20180185328-A1 MOBILIZING AGENTS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2018-07-05 US disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 US disclosed
EP-3156410-A1 POLYENE MACROLIDE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2017-04-19 EP disclosed
US-9586914-B2 Modulators of C3a receptors THE UNIVERSITY OF QUEENSLAND (AU) 2017-03-07 US disclosed
WO-2016191811-A1 MOBILIZING AGENTS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2016-12-08 WO disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 US disclosed
US-20140302069-A1 MODULATORS OF C3A RECEPTORS THE UNIVERSITY OF QUEENSLAND (AU) 2014-10-09 US disclosed
US-8455497-B2 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-06-04 US disclosed
EP-2253328-A1 Cycloalkyl inhibitors of potassium channel function Bristol-Myers Squibb Company (US) 2010-11-24 EP disclosed
EP-1866343-B1 PROCESS FOR THE PREPARATION OF STAR AND BLOCK-COPOLYMERS VIA EPOXY-FUNCTIONALIZED ALKOXYAMINES BASF SE (DE) 2010-09-29 EP disclosed
US-20090299013-A1 Process for the Preparation of Star and Block-Copolymers Via Epoxy-Functionalized Alkoxyamines CIBA SPECIALTY CHEMICALS CORP. 2009-12-03 US disclosed
US-20090299013-A1 Process for the Preparation of Star and Block-Copolymers Via Epoxy-Functionalized Alkoxyamines CIBA SPECIALTY CHEMICALS CORP. 2009-12-03 US disclosed